サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1497663

バイオマーカー市場：製品・サービス、タイプ、疾患、用途別-2024～2030年の世界予測

Biomarkers Market by Product & Service (Consumables, Services, Software), Type (Efficacy Biomarkers, Safety Biomarkers, Validation Biomarkers), Disease, Application - Global Forecast 2024-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 195 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.13円
バイオマーカー市場：製品・サービス、タイプ、疾患、用途別-2024～2030年の世界予測
出版日: 2024年06月05日
発行: 360iResearch
ページ情報: 英文 195 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

バイオマーカー市場規模は2023年に525億米ドルと推計され、2024年には596億9,000万米ドルに達し、CAGR 14.19％で2030年には1,329億8,000万米ドルに達すると予測されています。

バイオマーカーは、生物学的マーカーとも呼ばれ、生物学的状態や状態を示す測定可能な指標で、体液や組織から検出・定量されることが多いです。様々な生理学的・病理学的プロセスの存在を反映することができるため、病気の診断、治療効果の予測、病気の進行状況のモニタリングなど、医学の分野で広く利用されています。バイオマーカーの使用拡大は主に、慢性疾患の有病率の増加や、個人の特性、行動、危険因子に合わせた治療を行う個別化医療への評価の高まりによってもたらされています。しかし、バイオマーカー開発における課題には、発見と検証にかかる高いコストと複雑さ、規制上のハードル、信頼性と有効性を確保するための強固な臨床的検証の必要性などがあります。このような課題にもかかわらず、新たな健康の脅威に対する新しいバイオマーカーの開発、医薬品開発プロセスにおけるバイオマーカーへの重点的な取り組み、バイオマーカーの発見と応用を改善するための人工知能の統合は、より正確で効果的なヘルスケアソリューションへの道を開くものです。

主な市場の統計
基準年[2023］ 525億米ドル
予測年[2024] 596億9,000万米ドル
予測年 [2030] 1,329億8,000万米ドル
CAGR（%） 14.19%

地域別の洞察

南北アメリカのバイオマーカー市場は、先進的なヘルスケアインフラの存在と研究開発への投資により、力強い成長を示しています。米国は、臨床現場におけるバイオマーカーの大規模な導入と、バイオマーカー研究に対する政府機関の強力な支援によって、この成長に大きく貢献しています。さらに、慢性疾患の有病率の増加や個別化医療への強い関心が市場成長を促進する主な要因となっています。欧州は、高いヘルスケア支出と新技術の早期導入により、安定した市場成長を示しています。中東とアフリカは、ヘルスケアインフラの改善と個別化医療の利点に関する意識の高まりにより、成長の可能性を示しています。アジア太平洋地域は、急速な経済開拓、ヘルスケア支出の増加、ヘルスケアシステムの近代化を目指す政府の取り組みにより、バイオマーカー市場の急速な成長を示しています。人口の増加と疾病の発生率の増加がバイオマーカーの採用に寄与しています。さらに、この地域におけるバイオテクノロジー企業や研究機関の拡大が成長をさらに後押ししています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは、バイオマーカー市場におけるベンダーのポジショニングを評価する上で不可欠です。このマトリックスはベンダーの包括的な評価を提供し、ビジネス戦略や製品満足度に関連する重要な指標を検証します。この詳細な評価により、ユーザーは自らの要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功のレベルを表す4つの象限、すなわちForefront（F）、Pathfinder（P）、Niche（N）、Vital（V）に分類されます。

市場シェア分析

市場シェア分析は、バイオマーカー市場におけるベンダーの現状について、洞察に満ちた詳細な評価を提供する包括的なツールです。ベンダーの貢献度を綿密に比較・分析することで、各ベンダーの業績や市場シェア争いの際に直面する課題について、より深い理解を得ることができます。これらの貢献には、全体的な収益、顧客ベース、その他の重要な指標が含まれます。さらに、この分析では、調査した基準年の期間に観察された蓄積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合性に関する貴重な考察を提供しています。このような詳細な情報を得ることで、ベンダーは市場競争において優位に立つために、より多くの情報に基づいた意思決定を行い、効果的な戦略を考案することができます。

戦略分析と推奨

戦略分析は、世界マーケットで確固たる足場を築こうとする組織にとって不可欠です。企業は、バイオマーカー市場における現在の地位を徹底的に評価することで、長期的な願望に沿った情報に基づいた意思決定を行うことができます。この重要な評価には、組織のリソース、能力、全体的なパフォーマンスを徹底的に分析し、中核となる強みと改善すべき領域を特定することが含まれます。

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 慢性疾患の早期発見・診断におけるバイオマーカーの使用増加
      • バイオマーカー調査に対する政府と規制当局の支援
      • パーソナライズ医療におけるバイオマーカーの応用拡大
    • 抑制要因
      • バイオマーカーの開発に伴う高コストと技術的問題
    • 機会
      • バイオマーカーと人工知能および機械学習の統合
      • 高度な非侵襲性バイオマーカーの開発への関心の高まり
    • 課題
      • バイオマーカーの使用に関する倫理的および法的懸念
  • 市場セグメンテーション分析
    • 製品とサービス：生物学的データの複雑さを処理するための、高度で使いやすいバイオマーカーソフトウェアの採用が拡大しています。
    • アプリケーション：医薬品開発における製品の有効性と安全性を判断するためのバイオマーカーのアプリケーションの増加
  • 市場ディスラプション分析
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 価格分析
  • 技術分析
  • 特許分析
  • 貿易分析
  • 規制枠組みの分析

第6章 バイオマーカー市場製品・サービス別

  • 消耗品
  • サービス
  • ソフトウェア

第7章 バイオマーカー市場：タイプ別

  • 効能バイオマーカー
  • 安全性バイオマーカー
  • 検証バイオマーカー

第8章 バイオマーカー市場：疾患別

  • がん
  • 心血管疾患
  • 免疫疾患
  • 感染症
  • 神経疾患

第9章 バイオマーカー市場：用途別

  • 臨床診断
  • 臨床調査
  • 医薬品の発見と開発
  • 個別化医療

第10章 南北アメリカのバイオマーカー市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第11章 アジア太平洋地域のバイオマーカー市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第12章 欧州・中東・アフリカのバイオマーカー市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第13章 競合情勢

  • 市場シェア分析2023
  • FPNVポジショニングマトリックス, 2023
  • 競合シナリオ分析
    • オウルストーン・メディカルの斬新な取り組みがビル＆メリンダ・ゲイツ財団の資金援助を受ける
    • 転移性大腸がんの治療を強化する先駆的な調査協力
    • FDA、腫瘍治療薬のコンパニオン診断検査を規制するパイロットプログラムを開始
  • 戦略分析と提言

第14章 競合ポートフォリオ

  • 主要企業プロファイル
  • 主要製品ポートフォリオ
図表

LIST OF FIGURES

  • FIGURE 1. BIOMARKERS MARKET RESEARCH PROCESS
  • FIGURE 2. BIOMARKERS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BIOMARKERS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL BIOMARKERS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. BIOMARKERS MARKET DYNAMICS
  • FIGURE 7. GLOBAL BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL BIOMARKERS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL BIOMARKERS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL BIOMARKERS MARKET SIZE, BY DISEASE, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL BIOMARKERS MARKET SIZE, BY DISEASE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS BIOMARKERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS BIOMARKERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES BIOMARKERS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES BIOMARKERS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC BIOMARKERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC BIOMARKERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. BIOMARKERS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 24. BIOMARKERS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BIOMARKERS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BIOMARKERS MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL BIOMARKERS MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL BIOMARKERS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL BIOMARKERS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL BIOMARKERS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL BIOMARKERS MARKET SIZE, BY CONSUMABLES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL BIOMARKERS MARKET SIZE, BY SERVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL BIOMARKERS MARKET SIZE, BY SERVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL BIOMARKERS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL BIOMARKERS MARKET SIZE, BY SOFTWARE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL BIOMARKERS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL BIOMARKERS MARKET SIZE, BY PHARMACODYNAMIC BIOMARKERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL BIOMARKERS MARKET SIZE, BY PHARMACODYNAMIC BIOMARKERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL BIOMARKERS MARKET SIZE, BY PREDICTIVE BIOMARKERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL BIOMARKERS MARKET SIZE, BY PREDICTIVE BIOMARKERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL BIOMARKERS MARKET SIZE, BY PROGNOSTIC BIOMARKERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL BIOMARKERS MARKET SIZE, BY PROGNOSTIC BIOMARKERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL BIOMARKERS MARKET SIZE, BY SURROGATE BIOMARKERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL BIOMARKERS MARKET SIZE, BY SURROGATE BIOMARKERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL BIOMARKERS MARKET SIZE, BY SAFETY BIOMARKERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL BIOMARKERS MARKET SIZE, BY SAFETY BIOMARKERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL BIOMARKERS MARKET SIZE, BY VALIDATION BIOMARKERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL BIOMARKERS MARKET SIZE, BY VALIDATION BIOMARKERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL BIOMARKERS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL BIOMARKERS MARKET SIZE, BY CANCER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL BIOMARKERS MARKET SIZE, BY CANCER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL BIOMARKERS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL BIOMARKERS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL BIOMARKERS MARKET SIZE, BY IMMUNOLOGICAL DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL BIOMARKERS MARKET SIZE, BY IMMUNOLOGICAL DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL BIOMARKERS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL BIOMARKERS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL BIOMARKERS MARKET SIZE, BY NEUROLOGICAL DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL BIOMARKERS MARKET SIZE, BY NEUROLOGICAL DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL BIOMARKERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL BIOMARKERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL BIOMARKERS MARKET SIZE, BY CLINICAL RESEARCH, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL BIOMARKERS MARKET SIZE, BY CLINICAL RESEARCH, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 51. GLOBAL BIOMARKERS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 52. GLOBAL BIOMARKERS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 53. GLOBAL BIOMARKERS MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 54. GLOBAL BIOMARKERS MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 55. AMERICAS BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 56. AMERICAS BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 57. AMERICAS BIOMARKERS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 58. AMERICAS BIOMARKERS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 59. AMERICAS BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2018-2023 (USD MILLION)
  • TABLE 60. AMERICAS BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2024-2030 (USD MILLION)
  • TABLE 61. AMERICAS BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 62. AMERICAS BIOMARKERS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 63. AMERICAS BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 64. AMERICAS BIOMARKERS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 65. AMERICAS BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 66. AMERICAS BIOMARKERS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 67. ARGENTINA BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 68. ARGENTINA BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 69. ARGENTINA BIOMARKERS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 70. ARGENTINA BIOMARKERS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 71. ARGENTINA BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2018-2023 (USD MILLION)
  • TABLE 72. ARGENTINA BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2024-2030 (USD MILLION)
  • TABLE 73. ARGENTINA BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 74. ARGENTINA BIOMARKERS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 75. ARGENTINA BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 76. ARGENTINA BIOMARKERS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 77. BRAZIL BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 78. BRAZIL BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 79. BRAZIL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 80. BRAZIL BIOMARKERS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 81. BRAZIL BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2018-2023 (USD MILLION)
  • TABLE 82. BRAZIL BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2024-2030 (USD MILLION)
  • TABLE 83. BRAZIL BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 84. BRAZIL BIOMARKERS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 85. BRAZIL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 86. BRAZIL BIOMARKERS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 87. CANADA BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 88. CANADA BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 89. CANADA BIOMARKERS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 90. CANADA BIOMARKERS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 91. CANADA BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2018-2023 (USD MILLION)
  • TABLE 92. CANADA BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2024-2030 (USD MILLION)
  • TABLE 93. CANADA BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 94. CANADA BIOMARKERS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 95. CANADA BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 96. CANADA BIOMARKERS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 97. MEXICO BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 98. MEXICO BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 99. MEXICO BIOMARKERS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 100. MEXICO BIOMARKERS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 101. MEXICO BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2018-2023 (USD MILLION)
  • TABLE 102. MEXICO BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2024-2030 (USD MILLION)
  • TABLE 103. MEXICO BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 104. MEXICO BIOMARKERS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 105. MEXICO BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 106. MEXICO BIOMARKERS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 107. UNITED STATES BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 108. UNITED STATES BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 109. UNITED STATES BIOMARKERS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 110. UNITED STATES BIOMARKERS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 111. UNITED STATES BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2018-2023 (USD MILLION)
  • TABLE 112. UNITED STATES BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2024-2030 (USD MILLION)
  • TABLE 113. UNITED STATES BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 114. UNITED STATES BIOMARKERS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 115. UNITED STATES BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 116. UNITED STATES BIOMARKERS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 117. UNITED STATES BIOMARKERS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 118. UNITED STATES BIOMARKERS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC BIOMARKERS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC BIOMARKERS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2018-2023 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2024-2030 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC BIOMARKERS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC BIOMARKERS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC BIOMARKERS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 131. AUSTRALIA BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 132. AUSTRALIA BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 133. AUSTRALIA BIOMARKERS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 134. AUSTRALIA BIOMARKERS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 135. AUSTRALIA BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2018-2023 (USD MILLION)
  • TABLE 136. AUSTRALIA BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2024-2030 (USD MILLION)
  • TABLE 137. AUSTRALIA BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 138. AUSTRALIA BIOMARKERS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 139. AUSTRALIA BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 140. AUSTRALIA BIOMARKERS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 141. CHINA BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 142. CHINA BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 143. CHINA BIOMARKERS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 144. CHINA BIOMARKERS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 145. CHINA BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2018-2023 (USD MILLION)
  • TABLE 146. CHINA BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2024-2030 (USD MILLION)
  • TABLE 147. CHINA BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 148. CHINA BIOMARKERS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 149. CHINA BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 150. CHINA BIOMARKERS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 151. INDIA BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 152. INDIA BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 153. INDIA BIOMARKERS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 154. INDIA BIOMARKERS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 155. INDIA BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2018-2023 (USD MILLION)
  • TABLE 156. INDIA BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2024-2030 (USD MILLION)
  • TABLE 157. INDIA BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 158. INDIA BIOMARKERS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 159. INDIA BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 160. INDIA BIOMARKERS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 161. INDONESIA BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 162. INDONESIA BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 163. INDONESIA BIOMARKERS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 164. INDONESIA BIOMARKERS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 165. INDONESIA BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2018-2023 (USD MILLION)
  • TABLE 166. INDONESIA BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2024-2030 (USD MILLION)
  • TABLE 167. INDONESIA BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 168. INDONESIA BIOMARKERS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 169. INDONESIA BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 170. INDONESIA BIOMARKERS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 171. JAPAN BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 172. JAPAN BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 173. JAPAN BIOMARKERS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 174. JAPAN BIOMARKERS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 175. JAPAN BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2018-2023 (USD MILLION)
  • TABLE 176. JAPAN BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2024-2030 (USD MILLION)
  • TABLE 177. JAPAN BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 178. JAPAN BIOMARKERS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 179. JAPAN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 180. JAPAN BIOMARKERS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 181. MALAYSIA BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 182. MALAYSIA BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 183. MALAYSIA BIOMARKERS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 184. MALAYSIA BIOMARKERS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 185. MALAYSIA BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2018-2023 (USD MILLION)
  • TABLE 186. MALAYSIA BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2024-2030 (USD MILLION)
  • TABLE 187. MALAYSIA BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 188. MALAYSIA BIOMARKERS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 189. MALAYSIA BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 190. MALAYSIA BIOMARKERS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 191. PHILIPPINES BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 192. PHILIPPINES BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 193. PHILIPPINES BIOMARKERS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 194. PHILIPPINES BIOMARKERS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 195. PHILIPPINES BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2018-2023 (USD MILLION)
  • TABLE 196. PHILIPPINES BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2024-2030 (USD MILLION)
  • TABLE 197. PHILIPPINES BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 198. PHILIPPINES BIOMARKERS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 199. PHILIPPINES BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 200. PHILIPPINES BIOMARKERS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 201. SINGAPORE BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 202. SINGAPORE BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 203. SINGAPORE BIOMARKERS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 204. SINGAPORE BIOMARKERS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 205. SINGAPORE BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2018-2023 (USD MILLION)
  • TABLE 206. SINGAPORE BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2024-2030 (USD MILLION)
  • TABLE 207. SINGAPORE BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 208. SINGAPORE BIOMARKERS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 209. SINGAPORE BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 210. SINGAPORE BIOMARKERS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 211. SOUTH KOREA BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 212. SOUTH KOREA BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 213. SOUTH KOREA BIOMARKERS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 214. SOUTH KOREA BIOMARKERS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 215. SOUTH KOREA BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2018-2023 (USD MILLION)
  • TABLE 216. SOUTH KOREA BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2024-2030 (USD MILLION)
  • TABLE 217. SOUTH KOREA BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 218. SOUTH KOREA BIOMARKERS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 219. SOUTH KOREA BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 220. SOUTH KOREA BIOMARKERS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 221. TAIWAN BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 222. TAIWAN BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 223. TAIWAN BIOMARKERS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 224. TAIWAN BIOMARKERS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 225. TAIWAN BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2018-2023 (USD MILLION)
  • TABLE 226. TAIWAN BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2024-2030 (USD MILLION)
  • TABLE 227. TAIWAN BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 228. TAIWAN BIOMARKERS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 229. TAIWAN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 230. TAIWAN BIOMARKERS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 231. THAILAND BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 232. THAILAND BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 233. THAILAND BIOMARKERS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 234. THAILAND BIOMARKERS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 235. THAILAND BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2018-2023 (USD MILLION)
  • TABLE 236. THAILAND BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2024-2030 (USD MILLION)
  • TABLE 237. THAILAND BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 238. THAILAND BIOMARKERS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 239. THAILAND BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 240. THAILAND BIOMARKERS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 241. VIETNAM BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 242. VIETNAM BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 243. VIETNAM BIOMARKERS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 244. VIETNAM BIOMARKERS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 245. VIETNAM BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2018-2023 (USD MILLION)
  • TABLE 246. VIETNAM BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2024-2030 (USD MILLION)
  • TABLE 247. VIETNAM BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 248. VIETNAM BIOMARKERS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 249. VIETNAM BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 250. VIETNAM BIOMARKERS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 251. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 252. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 253. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 254. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 255. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2018-2023 (USD MILLION)
  • TABLE 256. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2024-2030 (USD MILLION)
  • TABLE 257. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 258. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 259. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 260. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 261. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 262. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 263. DENMARK BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 264. DENMARK BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 265. DENMARK BIOMARKERS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 266. DENMARK BIOMARKERS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 267. DENMARK BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2018-2023 (USD MILLION)
  • TABLE 268. DENMARK BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2024-2030 (USD MILLION)
  • TABLE 269. DENMARK BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 270. DENMARK BIOMARKERS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 271. DENMARK BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 272. DENMARK BIOMARKERS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 273. EGYPT BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 274. EGYPT BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 275. EGYPT BIOMARKERS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 276. EGYPT BIOMARKERS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 277. EGYPT BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2018-2023 (USD MILLION)
  • TABLE 278. EGYPT BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2024-2030 (USD MILLION)
  • TABLE 279. EGYPT BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 280. EGYPT BIOMARKERS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 281. EGYPT BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 282. EGYPT BIOMARKERS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 283. FINLAND BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 284. FINLAND BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 285. FINLAND BIOMARKERS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 286. FINLAND BIOMARKERS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 287. FINLAND BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2018-2023 (USD MILLION)
  • TABLE 288. FINLAND BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2024-2030 (USD MILLION)
  • TABLE 289. FINLAND BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 290. FINLAND BIOMARKERS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 291. FINLAND BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 292. FINLAND BIOMARKERS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 293. FRANCE BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 294. FRANCE BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 295. FRANCE BIOMARKERS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 296. FRANCE BIOMARKERS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 297. FRANCE BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2018-2023 (USD MILLION)
  • TABLE 298. FRANCE BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2024-2030 (USD MILLION)
  • TABLE 299. FRANCE BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 300. FRANCE BIOMARKERS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 301. FRANCE BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 302. FRANCE BIOMARKERS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 303. GERMANY BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 304. GERMANY BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 305. GERMANY BIOMARKERS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 306. GERMANY BIOMARKERS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 307. GERMANY BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2018-2023 (USD MILLION)
  • TABLE 308. GERMANY BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2024-2030 (USD MILLION)
  • TABLE 309. GERMANY BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 310. GERMANY BIOMARKERS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 311. GERMANY BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 312. GERMANY BIOMARKERS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 313. ISRAEL BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 314. ISRAEL BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 315. ISRAEL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 316. ISRAEL BIOMARKERS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 317. ISRAEL BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2018-2023 (USD MILLION)
  • TABLE 318. ISRAEL BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2024-2030 (USD MILLION)
  • TABLE 319. ISRAEL BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 320. ISRAEL BIOMARKERS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 321. ISRAEL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 322. ISRAEL BIOMARKERS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 323. ITALY BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 324. ITALY BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 325. ITALY BIOMARKERS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 326. ITALY BIOMARKERS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 327. ITALY BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2018-2023 (USD MILLION)
  • TABLE 328. ITALY BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2024-2030 (USD MILLION)
  • TABLE 329. ITALY BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 330. ITALY BIOMARKERS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 331. ITALY BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 332. ITALY BIOMARKERS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 333. NETHERLANDS BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 334. NETHERLANDS BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 335. NETHERLANDS BIOMARKERS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 336. NETHERLANDS BIOMARKERS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 337. NETHERLANDS BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2018-2023 (USD MILLION)
  • TABLE 338. NETHERLANDS BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2024-2030 (USD MILLION)
  • TABLE 339. NETHERLANDS BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 340. NETHERLANDS BIOMARKERS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 341. NETHERLANDS BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 342. NETHERLANDS BIOMARKERS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 343. NIGERIA BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 344. NIGERIA BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 345. NIGERIA BIOMARKERS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 346. NIGERIA BIOMARKERS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 347. NIGERIA BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2018-2023 (USD MILLION)
  • TABLE 348. NIGERIA BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2024-2030 (USD MILLION)
  • TABLE 349. NIGERIA BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 350. NIGERIA BIOMARKERS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 351. NIGERIA BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 352. NIGERIA BIOMARKERS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 353. NORWAY BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 354. NORWAY BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 355. NORWAY BIOMARKERS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 356. NORWAY BIOMARKERS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 357. NORWAY BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2018-2023 (USD MILLION)
  • TABLE 358. NORWAY BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2024-2030 (USD MILLION)
  • TABLE 359. NORWAY BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 360. NORWAY BIOMARKERS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 361. NORWAY BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 362. NORWAY BIOMARKERS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 363. POLAND BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 364. POLAND BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 365. POLAND BIOMARKERS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 366. POLAND BIOMARKERS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 367. POLAND BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2018-2023 (USD MILLION)
  • TABLE 368. POLAND BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2024-2030 (USD MILLION)
  • TABLE 369. POLAND BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 370. POLAND BIOMARKERS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 371. POLAND BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 372. POLAND BIOMARKERS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 373. QATAR BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 374. QATAR BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 375. QATAR BIOMARKERS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 376. QATAR BIOMARKERS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 377. QATAR BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2018-2023 (USD MILLION)
  • TABLE 378. QATAR BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2024-2030 (USD MILLION)
  • TABLE 379. QATAR BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 380. QATAR BIOMARKERS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 381. QATAR BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 382. QATAR BIOMARKERS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 383. RUSSIA BIOMARKERS MARKET SIZE,
目次
Product Code: MRR-A339DAEFACD9

[195 Pages Report] The Biomarkers Market size was estimated at USD 52.50 billion in 2023 and expected to reach USD 59.69 billion in 2024, at a CAGR 14.19% to reach USD 132.98 billion by 2030.

Biomarkers, also known as biological markers, a measurable indicators of some biological state or condition, often detected and quantified in body fluids or tissues. They are extensively used in medical science for diagnosing diseases, predicting treatment response, and monitoring the progress of disease, owing to their ability to reflect the presence of various physiological or pathological processes. The expansion of their use is primarily driven by the increasing prevalence of chronic diseases and a growing appreciation for personalized medicine, which tailors treatment to individual characteristics, behaviors, and risk factors. However, challenges in biomarker development include the high cost and complexity of discovery and validation, along with regulatory hurdles and the necessity for robust clinical validation to ensure reliability and efficacy. Despite these challenges, the development of novel biomarkers for emerging health threats, enhanced focus on biomarkers in drug development processes, and the integration of artificial intelligence to improve biomarker discovery and application pave the way for more precise and effective healthcare solutions.

KEY MARKET STATISTICS
Base Year [2023] USD 52.50 billion
Estimated Year [2024] USD 59.69 billion
Forecast Year [2030] USD 132.98 billion
CAGR (%) 14.19%

Regional Insights

The biomarker market in the Americas is showing robust growth, with the presence of advanced healthcare infrastructure and investment in research and development. The United States is the major contributor to this growth, driven by the large-scale implementation of biomarkers in clinical practices and strong support from government entities for biomarker research. Additionally, the increasing prevalence of chronic diseases and a strong focus on personalized medicine are major factors propelling market growth. Europe is displaying steady market growth owing to high healthcare spending and early adoption of new technologies. The Middle East and Africa are showing growth potential due to improving healthcare infrastructure and growing awareness about the benefits of personalized medicine. Asia-Pacific showcases rapid growth in the biomarker market, facilitated by rapid economic development, increasing healthcare expenditure, and government initiatives aimed at modernizing healthcare systems. Growing populations and increasing incidence of diseases contribute to the adoption of biomarkers. Moreover, the expansion of biotechnology companies and research institutions in this region further supports the growth.

Market Insights

  • Market Dynamics

The market dynamics represent an ever-changing landscape of the Biomarkers Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

    • Market Drivers
      • Increasing usage of biomarkers in early detection and diagnosis of chronic disease
      • Governments and regulatory support for biomarker research
      • Growing applications of biomarkers in personalized medicine
    • Market Restraints
      • High cost and technical issues associated with developing biomarkers
    • Market Opportunities
      • Integration of biomarkers with artificial intelligence and machine learning
      • Growing interest in developing advanced noninvasive biomarkers
    • Market Challenges
      • Ethical and legal concerns regarding the use of biomarkers
  • Market Segmentation Analysis
    • Product & Service: Growing adoption of sophisticated and user-friendly biomarker software to handle the complexity of biological data
    • Application: Growing applications of biomarkers in drug development to determine the efficacy and safety of the product
  • Market Disruption Analysis
  • Porter's Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Biomarkers Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Biomarkers Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Owlstone Medical's Novel Initiatives Receive the Bill & Melinda Gates Foundation Funding

Owlstone Medical has received significant financial funding from the Bill & Melinda Gates Foundation to enhance early disease detection using its innovative Breath Biopsy platform. This includes a USD 5 million equity investment and an additional USD 1.5 million in grant funding. The grant is focused on identifying volatile organic compound (VOC) biomarkers for tuberculosis (TB) and human immunodeficiency virus (HIV). [Published On: 2024-04-25]

Pioneering Research Collaboration to Enhance Treatment for Metastatic Colorectal Cancer

The National Comprehensive Cancer Network (NCCN) has collaborated with Fight Colorectal Cancer (Fight CRC) and Pfizer to provide funding aimed at advancing biomarker-directed therapies for metastatic colorectal cancer. This significant financial support is designated for innovative clinical studies that are focused on identifying and utilizing biomarkers to improve the effectiveness and precision of treatments for patients battling this advanced stage of colorectal cancer. [Published On: 2023-08-09]

FDA Initiates Pilot Program to Regulate Companion Diagnostic Tests for Oncology Drugs

The U.S. Food and Drug Administration (FDA) has introduced a pivotal pilot program focused on refining the integration of specific oncology drugs with their corresponding in-vitro diagnostic tests. This initiative primarily addresses the critical use of laboratory-developed tests (LDTs) to identify specific biomarkers used for selecting cancer treatment. The program aims to establish and make public the minimum performance characteristics necessary for diagnostic tests utilized in clinical trials. [Published On: 2023-06-21]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Biomarkers Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Biomarkers Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Abcam PLC, APIS Assay Technologies Limited, Augurex Life Sciences Corp, Bio-Rad Laboratories, Inc., BioAgilytix, Biocrates Life Sciences AG, Biofourmis Inc., Biognosys AG, BioStarks, Charles River Laboratories, Inc., Elo Health, Inc., F. Hoffmann-La Roche, Ltd., Merck KgaA, Nightingale Health Plc, Owkin Inc., Owlstone Medical Limited, PerkinElmer, Inc., Personalis, Inc., Proteomedix AG, QIAGEN GmbH, Siemens Healthineers AG, Sino Biological Inc., Thermo Fisher Scientific, Inc., and VivoSense, Inc.

Market Segmentation & Coverage

This research report categorizes the Biomarkers Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product & Service
    • Consumables
    • Services
    • Software
  • Type
    • Efficacy Biomarkers
      • Pharmacodynamic Biomarkers
      • Predictive Biomarkers
      • Prognostic Biomarkers
      • Surrogate Biomarkers
    • Safety Biomarkers
    • Validation Biomarkers
  • Disease
    • Cancer
    • Cardiovascular Diseases
    • Immunological Diseases
    • Infectious Diseases
    • Neurological Diseases
  • Application
    • Clinical Diagnostics
    • Clinical Research
    • Drug Discovery & Development
    • Personalized Medicine
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing usage of biomarkers in early detection and diagnosis of chronic disease
      • 5.1.1.2. Governments and regulatory support for biomarker research
      • 5.1.1.3. Growing applications of biomarkers in personalized medicine
    • 5.1.2. Restraints
      • 5.1.2.1. High cost and technical issues associated with developing biomarkers
    • 5.1.3. Opportunities
      • 5.1.3.1. Integration of biomarkers with artificial intelligence and machine learning
      • 5.1.3.2. Growing interest in developing advanced noninvasive biomarkers
    • 5.1.4. Challenges
      • 5.1.4.1. Ethical and legal concerns regarding the use of biomarkers
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product & Service: Growing adoption of sophisticated and user-friendly biomarker software to handle the complexity of biological data
    • 5.2.2. Application: Growing applications of biomarkers in drug development to determine the efficacy and safety of the product
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Biomarkers Market, by Product & Service

  • 6.1. Introduction
  • 6.2. Consumables
  • 6.3. Services
  • 6.4. Software

7. Biomarkers Market, by Type

  • 7.1. Introduction
  • 7.2. Efficacy Biomarkers
  • 7.3. Safety Biomarkers
  • 7.4. Validation Biomarkers

8. Biomarkers Market, by Disease

  • 8.1. Introduction
  • 8.2. Cancer
  • 8.3. Cardiovascular Diseases
  • 8.4. Immunological Diseases
  • 8.5. Infectious Diseases
  • 8.6. Neurological Diseases

9. Biomarkers Market, by Application

  • 9.1. Introduction
  • 9.2. Clinical Diagnostics
  • 9.3. Clinical Research
  • 9.4. Drug Discovery & Development
  • 9.5. Personalized Medicine

10. Americas Biomarkers Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Biomarkers Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Biomarkers Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Owlstone Medical's Novel Initiatives Receive the Bill & Melinda Gates Foundation Funding
    • 13.3.2. Pioneering Research Collaboration to Enhance Treatment for Metastatic Colorectal Cancer
    • 13.3.3. FDA Initiates Pilot Program to Regulate Companion Diagnostic Tests for Oncology Drugs
  • 13.4. Strategy Analysis & Recommendation

14. Competitive Portfolio

  • 14.1. Key Company Profiles
  • 14.2. Key Product Portfolio